7D Surgical Acquired By Seaspine
7D Surgical was acquired by SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders. The agreement is a cash and…
Miroculus Funding News
In February 2021, Miroculus closed a Series B financing extension bringing the total capital raised in the round to $45 million. bwnews.pr/3s9abDsbwnews.pr/3s9abDs
Notch Therapeutics Raises $85M Series A Financing
TIAP portfolio company Notch Therapeutics has announced one of the largest Series A financing rounds in the history of Canadian biotech. We are proud to say that we were there…
Webinar February 24, 2021: Adventures in Drug Hunting – Identify and Advance Your Drug-Like Molecule
On February 24, 2021 TIAP hosted a LAB150 webinar entitled Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule. Here is the full description of the webinar content: In the…
TIAP & Amgen Co-funds transformative projects to support new venture development
December 8, 2020 TIAP announces co-funding of transformative projects with Amgen to support new venture development Toronto Innovation Acceleration Partners (TIAP) is excited to announce co-investments made with a key…
Webinar: Staying on Target – How to Determine if Your Research Program is Ready for Drug Delivery
Staying on Target: How to Determine if Your Research Program is Ready for Drug Discovery LAB150 Presents: A 3-part Webinar Series on Drug Discovery and Development November 17, 2020 -…
Funding for Zucara Therapeutics Expansion Into ZT-01 Development Program to Type 2 Diabetes
November 2, 2020: Zucara Therapeutics Inc., a diabetes life sciences startup funded by TIAP and adMare BioInnovations, announced today that it has received funding from NRC IRAP and MITAS for…
FedDev Ontario Funding Support – Portfolio Investments
On October 9, 2020, the Honourable Mélanie Joly, then Minister of Economic Development and Official Languages and Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario)…
Bristol Myers Squibb Enters Agreement to Acquire Forbius
TIAP portfolio company Forbius announced on August 24, 2020 that they have entered into an acquisition deal with Bristol Myers Squibb. BMS is adding lead TGF-beta asset to its portfolio.…
TIAP CEO appointed to Govt of Canada’s COVID-19 Task Force
TIAP's President & CEO, Parimal Nathwani, is appointed to the Government of Canada's COVID-19 Core Task Force to advise on funding of new and potential therapies for COVID-19: https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01780.html